Company: Merck & Co.
Job title: Vice President, External Collaborations
Evaluating the Importance of Independent Action in ADC Combination Trials 8:30 am
*Virtual* Highlighting how immuno oncology drugs are failing at an unprecedented rate -perhaps because too much reliance has been placed on preclinical thinking about synergy Based on the mathematics of independent action, synergy has not been seen in any immune oncology registration trials to date To progress the development of combinations of ADC and PD-1…Read more
day: day 2- am